AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aclaris Therapeutics, Inc.

$3.97 +$1.09 (+37.85%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$3.99
Day Range
$3.87$4.07
Year Range
$2.10$6.60
Market Cap
584.38M
AVG Volume
2.67M
Trailing/Forward PE
-6.84/-
PEG ratio
-0.31
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACRS Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q28.22M
26 Q18.37M
25 Q47.83M
25 Q315.74M
25 Q216.79M
25 Q117.78M
24 Q418.72M
24 Q327.08M
24 Q232.02M
24 Q131.12M
Net Income (USD) · TTM
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACRS Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-75.74M
26 Q1-69.66M
25 Q4-64.92M
25 Q3-141.68M
25 Q2-134.65M
25 Q1-130.21M
24 Q4-132.06M
24 Q3-37M
24 Q2-58.68M
24 Q1-77.26M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACRS Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-86.31M
26 Q1-80.48M
25 Q4-76.38M
25 Q3-153.32M
25 Q2-146.64M
25 Q1-141.08M
24 Q4-141.93M
24 Q3-46.3M
24 Q2-67.41M
24 Q1-86.37M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ACRS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Aclaris Therapeutics, Inc.
ACRS
Stockpicker

Video analysis: ACRS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ACRS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.